Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 6Lymphatic Metastasis 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Breast Neoplasms 3Stomach Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Carcinoma, Transitional Cell 2Vulvar Neoplasms 1Urologic Neoplasms 1Ureteral Neoplasms 1Recurrence 1Radiation Injuries 1Prostate Adenocarcinoma 1Postoperative Complications 1Ovarian Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Mixed Tumor, Mesodermal 1Melanoma 1Lymphedema 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Disease 1Cholangiocarcinoma 1

Interventions

belinostat 2Radiotherapy 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Lymph Node Excision 1Indocyanine Green 1Ifosfamide 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Mixed Tumor, Mesodermal × Lymph Node Excision × Clear all
NCT01737619 2026-05-04

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
101 enrolled 8 charts

Mixed Tumor, Mesodermal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡